Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
Little-Known Billionaire's Book is the Holy Grail for Investors
OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed?
ZIOPHARM Presents Updated Results from Phase 1 Ad-RTS-IL-12 Study in Advanced Melanoma at ASCO
Morning Market Losers
Bass' New Buy - ZIOPHARM Oncology Inc.
ZIOPHARM Offers Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 in Advanced Melanoma
5 Stocks Under $10 Set to Soar
The Far-Off Four, 52-week Lows Held by Gurus
Leaders of TheStreet's Drug Approval Contest